peer reviewedTo facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in terms of the depth and global context of this knowledge, we have created the Global Parkinson's Genetics Program (GP2; www.gp2.org). GP2 is the first supported resource project of the Aligning Science Across Parkinson's (ASAP) initiative, an audacious effort supporting PD research.9 GP2 is geared toward creating a worldwide collaborative effort that will first dramatically accelerate the identification of genetic contributors to disease and second establish a network of researchers who can best leverage this understanding to research, diagnose, and treat PD worldwide. Here we describe our mission, the path we have proposed to achie...
The Aligning Science Across Parkinson's (ASAP) initiative was set up to improve understanding of the...
Parkinson's disease (PD) is the fastest growing neurological disorder worldwide, taking into account...
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 m...
To facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in te...
Abstract The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an ef...
\ua9 2023, Springer Nature Limited. The Global Parkinson’s Genetics Program (GP2) will genotype over...
Abstract: Parkinson\u2019s disease (PD) is the fastest-growing neurodegenerative disorder, currently...
Neurologists commonly lack reliable reference data to be able to offer tailored counseling and treat...
In May 2023, GP2 announced the fifth data release on the Terra platform in collaboration with AMP® P...
Parkinson's disease (PD) is a neurodegenerative disease with an often complex component identifiable...
Over the last decades, genetics has been the engine that has pushed us along on our voyage to unders...
BackgroundParkinson's disease (PD) is a neurodegenerative disease with an often complex component id...
The Foundational Data Initiative for Parkinson Disease (FOUNDIN-PD) is an international collaboratio...
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD)...
Background: Parkinson's disease (PD) is a neurodegenerative disease with an often complex component ...
The Aligning Science Across Parkinson's (ASAP) initiative was set up to improve understanding of the...
Parkinson's disease (PD) is the fastest growing neurological disorder worldwide, taking into account...
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 m...
To facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in te...
Abstract The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an ef...
\ua9 2023, Springer Nature Limited. The Global Parkinson’s Genetics Program (GP2) will genotype over...
Abstract: Parkinson\u2019s disease (PD) is the fastest-growing neurodegenerative disorder, currently...
Neurologists commonly lack reliable reference data to be able to offer tailored counseling and treat...
In May 2023, GP2 announced the fifth data release on the Terra platform in collaboration with AMP® P...
Parkinson's disease (PD) is a neurodegenerative disease with an often complex component identifiable...
Over the last decades, genetics has been the engine that has pushed us along on our voyage to unders...
BackgroundParkinson's disease (PD) is a neurodegenerative disease with an often complex component id...
The Foundational Data Initiative for Parkinson Disease (FOUNDIN-PD) is an international collaboratio...
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD)...
Background: Parkinson's disease (PD) is a neurodegenerative disease with an often complex component ...
The Aligning Science Across Parkinson's (ASAP) initiative was set up to improve understanding of the...
Parkinson's disease (PD) is the fastest growing neurological disorder worldwide, taking into account...
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 m...